Ocugen Inc OCGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:38 PM EDT
7.65quote price arrow up+0.12 (+1.59%)
Volume
100,463
Close
7.53quote price arrow down-0.08 (-1.05%)
Volume
14,903,433
52 week range
0.25 - 18.77
Loading...
  • Open7.53
  • Day High8.08
  • Day Low7.52
  • Prev Close7.61
  • 52 Week High18.77
  • 52 Week High Date02/08/21
  • 52 Week Low0.25
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap1.497B
  • Shares Out198.76M
  • 10 Day Average Volume17.01M
  • Dividend-
  • Dividend Yield-
  • Beta4.51
  • YTD % Change311.48

KEY STATS

  • Open7.53
  • Day High8.08
  • Day Low7.52
  • Prev Close7.61
  • 52 Week High18.77
  • 52 Week High Date02/08/21
  • 52 Week Low0.25
  • 52 Week Low Date11/02/20
  • Market Cap1.497B
  • Shares Out198.76M
  • 10 Day Average Volume17.01M
  • Dividend-
  • Dividend Yield-
  • Beta4.51
  • YTD % Change311.48

RATIOS/PROFITABILITY

  • EPS (TTM)-0.27
  • P/E (TTM)-28.21
  • Fwd P/E (NTM)-121.45
  • EBITDA (MRQ)-46.499M
  • ROE (MRQ)-72.19%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-58,552.65%
  • Debt To Equity (MRQ)1.44%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocugen Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion...
Shankar Musunuri Ph.D.
Chairman
Sanjay Subramanian
Chief Financial Officer
Address
263 GREAT VALLEY PARKWAY
Malvern, PA
19355
United States

Top Peers

SYMBOLLASTCHG%CHG
REPL
Replimune Group Inc
32.26-1.41-4.19%
ALVR
Allovir Inc
23.10-0.24-1.03%
ISEE
Iveric Bio Inc
16.37+0.14+0.86%
PRLD
Prelude Therapeutics Inc
34.64-0.86-2.42%
KDMN
Kadmon Holdings Inc
8.83-0.06-0.67%